Its application requires only a minimal incision, and the glue is directly introduced into the fractured area, sealing bone fragments in minutes. China holds national and international patents on Bone-02, balancing technological protection with plans aimed at benefiting the global medical community. More broadly, China has consolidated itself in recent years as a key player in biotechnology innovation applied to medicine. With strong public and private investments, regulatory renewal, and scientific research promotion, the country has exponentially increased its production of innovative medicines, clinical trials, and new technologies, outpacing many traditional powers in volume and pace. Bone-02 exemplifies this vanguard: a product inspired by nature and developed with high technology that could radically change how the world repairs bone fractures, benefiting millions of patients and the global health system.